Abstract:BACKGROUND: Tumor necrosis factor-α (TNF-α) is involved in inflammatory responses and promotes cell death and the inhibition of osteogenic differentiation. MicroRNA (miRNA) plays a crucial role in the infected bone diseases, however, the biological role of miRNAs in inflammation-induced impaired osteogenic differentiation remains unclear. This study aimed to explore the role of miRNA-18a-5p (miR-18a) in regulating PANoptosis and osteogenic differentiation in an inflammatory environment via hypoxia-inducible factor-1α (HIF1-α).METHODS: The expression of miR-18a in MC3T3-E1 cells was analyzed using quantitative reverse transcription-polymerase chain reaction in an inflammatory environment induced by TNF-α. The expression of HIF1-α and NLRP3 in LV-miR-18a or sh-miR-18a cells was analyzed using western blotting. Fluorescence imaging for cell death, flow cytometry, and alkaline phosphatase activity analysis were used to analyze the role of miR-18a in TNF-α-induced PANoptosis and the inhibition of osteogenic differentiation. An animal model of infectious bone defect was established to validate the regulatory role of miR-18a in an inflammatory environment.RESULTS: The expression of miRNA-18a in the MC3T3-E1 cell line was significantly lower under TNF-α stimulation than in the normal environment. miR-18a significantly inhibited the expression of HIF1-α and NLRP3, and inhibition of HIF1-α expression further inhibited NLRP3 expression. Furthermore, inhibition of miR-18a expression promoted the TNF-α-induced PANoptosis and inhibition of osteogenic differentiation, whereas miR-18a overexpression and the inhibition of both HIF1-α and NLRP3 reduced the effects of TNF-α. These findings are consistent with those of the animal experiments.CONCLUSION: miRNA-18a negatively affects HIF1-α/NLRP3 expression, inhibits inflammation-induced PANoptosis, and impairs osteogenic differentiation. Thus, it is a potential therapeutic candidate for developing anti-inflammatory strategies for infected bone diseases.

Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis.

Tumor Necrosis Factor-α Inhibits Bone Marrow Stem Cell Differentiation into Osteoblasts by Downregulating Microrna-34A Expression.

TNF-αinhibits Mbmscs Osteoporosis Through Mir-21

Tumour Necrosis Factor Α Regulates the Mir‐27a‐3p–sfrp1 Axis in a Mouse Model of Osteoporosis

Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by inhibiting semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency induced osteoporosis

Dysregulation of the Mir-146A-smad4 Axis Impairs Osteogenesis of Bone Mesenchymal Stem Cells under Inflammation

Tumor Necrosis Factor-Α Suppresses Adipogenic and Osteogenic Differentiation of Human Periodontal Ligament Stem Cell by Inhibiting Mir-21/Spry1 Functional Axis.

MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA

TNF-α Inhibits FoxO1 by Upregulating Mir-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells During Osteoporosis

Tumor Necrosis Factor-α Alters the Modulatory Effects of Mesenchymal Stem Cells on Osteoclast Formation and Function

TNF-α Suppresses Osteogenic Differentiation of MSCs by Accelerating P2Y2 Receptor in Estrogen-Deficiency Induced Osteoporosis

miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis

TNF-α-induced NF-κB Activation Upregulates Microrna-150-3p and Inhibits Osteogenesis of Mesenchymal Stem Cells by Targeting Β-Catenin.

Mir-155 Modulates TNF-α-inhibited Osteogenic Differentiation by Targeting SOCS1 Expression

Author Correction: Mir-21 Deficiency Inhibits Osteoclast Function and Prevents Bone Loss in Mice

MiR-21 regulates osteogenesis of human marrow-derived mesenchymal stem cells

IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem Cell Impairment and Tumorigenesis Via NFκB Signaling.

MicroRNA-18a regulates the Pyroptosis, Apoptosis, and Necroptosis (PANoptosis) of osteoblasts induced by tumor necrosis factor-α via hypoxia-inducible factor-1α

Melatonin Reversed Tumor Necrosis Factor-Alpha-inhibited Osteogenesis of Human Mesenchymal Stem Cells by Stabilizing SMAD1 Protein.

Estrogen inhibits osteoclasts formation and bone resorption via microRNA‐27a targeting PPARγ and APC

Mir-21 Synergizes with BMP9 in Osteogenic Differentiation by Activating the BMP9/Smad Signaling Pathway in Murine Multilineage Cells.